Global Trazodone Hydrochloride (API) Market Growth 2025-2031

Publication ID:

LPI03255678

Publication Date:

March 26, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Trazodone Hydrochloride (API) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Trazodone, a phenylpiperazine鈥搕riazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
Trazodone hydrochloride (API) consumed in USA are mostly imported from overseas. Major companies are Angelini, Mylan, SST Corporation, The Piramal Group. The sales market share of the four companies has reached 53%. The local factory, Teva occupied about 40% market share.
The 鈥淭razodone Hydrochloride (API) Industry Forecast鈥� looks at past sales and reviews total world Trazodone Hydrochloride (API) sales in 2024, providing a comprehensive analysis by region and market sector of projected Trazodone Hydrochloride (API) sales for 2025 through 2031. With Trazodone Hydrochloride (API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Trazodone Hydrochloride (API) industry.
This Insight Report provides a comprehensive analysis of the global Trazodone Hydrochloride (API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Trazodone Hydrochloride (API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Trazodone Hydrochloride (API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Trazodone Hydrochloride (API) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Trazodone Hydrochloride (API).
This report presents a comprehensive overview, market shares, and growth opportunities of Trazodone Hydrochloride (API) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Trazodone Hydrochloride (API)
Others
Segmentation by Application:
Antidepression
Anxiolytic
Hypnotic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Teva
Angelini
Mylan
Fermion
The Piramal Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Trazodone Hydrochloride (API) market?
What factors are driving Trazodone Hydrochloride (API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Trazodone Hydrochloride (API) market opportunities vary by end market size?
How does Trazodone Hydrochloride (API) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Trazodone Hydrochloride (API) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Trazodone Hydrochloride (API) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Trazodone Hydrochloride (API) by Country/Region, 2020, 2024 & 2031
2.2 Trazodone Hydrochloride (API) Segment by Type
2.2.1 Trazodone Hydrochloride (API)
2.2.2 Others
2.3 Trazodone Hydrochloride (API) Sales by Type
2.3.1 Global Trazodone Hydrochloride (API) Sales Market Share by Type (2020-2025)
2.3.2 Global Trazodone Hydrochloride (API) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Trazodone Hydrochloride (API) Sale Price by Type (2020-2025)
2.4 Trazodone Hydrochloride (API) Segment by Application
2.4.1 Antidepression
2.4.2 Anxiolytic
2.4.3 Hypnotic
2.4.4 Others
2.5 Trazodone Hydrochloride (API) Sales by Application
2.5.1 Global Trazodone Hydrochloride (API) Sale Market Share by Application (2020-2025)
2.5.2 Global Trazodone Hydrochloride (API) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Trazodone Hydrochloride (API) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Trazodone Hydrochloride (API) Breakdown Data by Company
3.1.1 Global Trazodone Hydrochloride (API) Annual Sales by Company (2020-2025)
3.1.2 Global Trazodone Hydrochloride (API) Sales Market Share by Company (2020-2025)
3.2 Global Trazodone Hydrochloride (API) Annual Revenue by Company (2020-2025)
3.2.1 Global Trazodone Hydrochloride (API) Revenue by Company (2020-2025)
3.2.2 Global Trazodone Hydrochloride (API) Revenue Market Share by Company (2020-2025)
3.3 Global Trazodone Hydrochloride (API) Sale Price by Company
3.4 Key Manufacturers Trazodone Hydrochloride (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Trazodone Hydrochloride (API) Product Location Distribution
3.4.2 Players Trazodone Hydrochloride (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Trazodone Hydrochloride (API) by Geographic Region
4.1 World Historic Trazodone Hydrochloride (API) Market Size by Geographic Region (2020-2025)
4.1.1 Global Trazodone Hydrochloride (API) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Trazodone Hydrochloride (API) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Trazodone Hydrochloride (API) Market Size by Country/Region (2020-2025)
4.2.1 Global Trazodone Hydrochloride (API) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Trazodone Hydrochloride (API) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Trazodone Hydrochloride (API) Sales Growth
4.4 APAC Trazodone Hydrochloride (API) Sales Growth
4.5 Europe Trazodone Hydrochloride (API) Sales Growth
4.6 Middle East & Africa Trazodone Hydrochloride (API) Sales Growth
5 Americas
5.1 Americas Trazodone Hydrochloride (API) Sales by Country
5.1.1 Americas Trazodone Hydrochloride (API) Sales by Country (2020-2025)
5.1.2 Americas Trazodone Hydrochloride (API) Revenue by Country (2020-2025)
5.2 Americas Trazodone Hydrochloride (API) Sales by Type (2020-2025)
5.3 Americas Trazodone Hydrochloride (API) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Trazodone Hydrochloride (API) Sales by Region
6.1.1 APAC Trazodone Hydrochloride (API) Sales by Region (2020-2025)
6.1.2 APAC Trazodone Hydrochloride (API) Revenue by Region (2020-2025)
6.2 APAC Trazodone Hydrochloride (API) Sales by Type (2020-2025)
6.3 APAC Trazodone Hydrochloride (API) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Trazodone Hydrochloride (API) by Country
7.1.1 Europe Trazodone Hydrochloride (API) Sales by Country (2020-2025)
7.1.2 Europe Trazodone Hydrochloride (API) Revenue by Country (2020-2025)
7.2 Europe Trazodone Hydrochloride (API) Sales by Type (2020-2025)
7.3 Europe Trazodone Hydrochloride (API) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Trazodone Hydrochloride (API) by Country
8.1.1 Middle East & Africa Trazodone Hydrochloride (API) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Trazodone Hydrochloride (API) Revenue by Country (2020-2025)
8.2 Middle East & Africa Trazodone Hydrochloride (API) Sales by Type (2020-2025)
8.3 Middle East & Africa Trazodone Hydrochloride (API) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Trazodone Hydrochloride (API)
10.3 Manufacturing Process Analysis of Trazodone Hydrochloride (API)
10.4 Industry Chain Structure of Trazodone Hydrochloride (API)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Trazodone Hydrochloride (API) Distributors
11.3 Trazodone Hydrochloride (API) Customer
12 World Forecast Review for Trazodone Hydrochloride (API) by Geographic Region
12.1 Global Trazodone Hydrochloride (API) Market Size Forecast by Region
12.1.1 Global Trazodone Hydrochloride (API) Forecast by Region (2026-2031)
12.1.2 Global Trazodone Hydrochloride (API) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Trazodone Hydrochloride (API) Forecast by Type (2026-2031)
12.7 Global Trazodone Hydrochloride (API) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Trazodone Hydrochloride (API) Product Portfolios and Specifications
13.1.3 Teva Trazodone Hydrochloride (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Angelini
13.2.1 Angelini Company Information
13.2.2 Angelini Trazodone Hydrochloride (API) Product Portfolios and Specifications
13.2.3 Angelini Trazodone Hydrochloride (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Angelini Main Business Overview
13.2.5 Angelini Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Trazodone Hydrochloride (API) Product Portfolios and Specifications
13.3.3 Mylan Trazodone Hydrochloride (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Fermion
13.4.1 Fermion Company Information
13.4.2 Fermion Trazodone Hydrochloride (API) Product Portfolios and Specifications
13.4.3 Fermion Trazodone Hydrochloride (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Fermion Main Business Overview
13.4.5 Fermion Latest Developments
13.5 The Piramal Group
13.5.1 The Piramal Group Company Information
13.5.2 The Piramal Group Trazodone Hydrochloride (API) Product Portfolios and Specifications
13.5.3 The Piramal Group Trazodone Hydrochloride (API) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 The Piramal Group Main Business Overview
13.5.5 The Piramal Group Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂